Henlez

Copenhagen, Denmark

Henlez provides biologic solutions to manage recurrent and follicular skin disorders.

$988K raised

Oct 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Henlez raised?

Henlez has raised $988K in total funding. The most recent round was Seed. The last funding was announced in October 2022.

Who are Henlez's investors?

Henlez's investors include EIR Ventures, Karolinska.

Where is Henlez headquartered?

Henlez is headquartered in Copenhagen, Denmark.

What does Henlez do?

Henlez provides biologic solutions to manage recurrent and follicular skin disorders.

What stage is Henlez at?

Henlez is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2022.

MLA

"Henlez — Funding & Investors." VCBacked, October 24, 2022, https://www.vcbacked.co/company/henlez. Accessed July 2, 2026.

APA

VCBacked. (2022). Henlez — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/henlez

Wikipedia (cite web)

{{cite web |title=Henlez — Funding & Investors |url=https://www.vcbacked.co/company/henlez |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2022.